litlas
Log inCreate account

Maura L. Gillison

Active 1992–2025

159
Papers
57,321
Citations
98
h-index
149
i10-index

Citations

Citations per year for Maura L. Gillison1992: 3 citations1993: 6 citations1994: 13 citations1995: 10 citations1996: 8 citations1997: 12 citations1998: 3 citations1999: 7 citations2000: 8 citations2001: 32 citations2002: 48 citations2003: 55 citations2004: 49 citations2005: 72 citations2006: 97 citations2007: 108 citations2008: 184 citations2009: 285 citations2010: 320 citations2011: 351 citations2012: 458 citations2013: 472 citations2014: 529 citations2015: 494 citations2016: 438 citations2017: 577 citations2018: 469 citations2019: 2,175 citations2020: 2,352 citations2021: 2,140 citations2022: 1,609 citations2023: 1,031 citations2024: 1,682 citations2025: 835 citations2026: 14 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,091 citing papers, 28.4% of this breakdownChina: 1,548 citing papers, 10.7% of this breakdownUnited Kingdom: 713 citing papers, 5% of this breakdownGermany: 684 citing papers, 4.8% of this breakdownItaly: 635 citing papers, 4.4% of this breakdownFrance: 563 citing papers, 3.9% of this breakdownCanada: 549 citing papers, 3.8% of this breakdownJapan: 496 citing papers, 3.4% of this breakdownAustralia: 392 citing papers, 2.7% of this breakdownNetherlands: 388 citing papers, 2.7% of this breakdownSpain: 341 citing papers, 2.4% of this breakdownIndia: 338 citing papers, 2.3% of this breakdown
0%28.4%Other 25.5%

Institutions

Fields

  • Medicine76.3%
  • Biochemistry, Genetics and Molecular Biology13.8%
  • Immunology and Microbiology4%
  • Dentistry2%
  • Engineering0.7%
  • Physics and Astronomy0.6%
  • Other2.6%

Topics

  • Head and Neck Cancer Studies15.4%
  • Cancer Immunotherapy and Biomarkers7.6%
  • Cervical Cancer and HPV Research5.5%
  • Esophageal Cancer Research and Treatment3.2%
  • Oral Health Pathology and Treatment3%
  • Immunotherapy and Immune Responses2.5%
  • Other62.8%

Coauthors

All papers

Open in search
  1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J. Geese, Justin Kopit, James W. Shaw, Maura L. Gillison - New England Journal of Medicine 2016 cited by 5,078

  2. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

    Authors: K. Kian Ang, Jonathan Harris, Richard Wheeler, Randal S. Weber, David I. Rosenthal, Phuc Félix Nguyen‐Tan, William H. Westra, Christine H. Chung, Richard C. Jordan, Charles Lu, Harold Kim, Rita Axelrod, C. Craig Silverman, Kevin P. Redmond, Maura L. Gillison - New England Journal of Medicine 2010 cited by 6,532

  3. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

    Authors: Yanshuo Chu, Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R. Ingram, Krupa Thakkar, Jiang‐Jiang Qin, Minghao Dang, Xiuning Le, Can Hu, Qing Deng, Ansam Sinjab, Pravesh Gupta, Ruiping Wang, Dapeng Hao, Fuduan Peng, Xinmiao Yan, Yunhe Liu, Shumei Song, Shaojun Zhang, John V. Heymach, Alexandre Reuben, Yasir Y. Elamin, Melissa Pool Pizzi, Yang Lü, Rossana Lazcano, Jian Hu, Mingyao Li, Michael A. Curran, P. Andrew Futreal, Anirban Maitra, Amir A. Jazaeri, Jaffer A. Ajani, Charles Swanton, Xiangdong Cheng, Hussein A. Abbas, Maura L. Gillison, Krishna Bhat, Alexander J. Lazar, Michael R. Green, Kevin Litchfield, Humam Kadara, Cassian Yee, Linghua Wang - Nature Medicine 2023 cited by 485

  4. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: David G. Pfister, Sharon Spencer, David J. Adelstein, Douglas R. Adkins, Yoshimi Anzai, David M. Brizel, Justine Y. Bruce, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Moon J. Fenton, Robert L. Foote, Thomas J. Galloway, Maura L. Gillison, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James W. Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Gregory S. Weinstein, Matthew E. Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 cited by 1,374

  5. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

    Authors: Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer, Brenda Y. Hernandez, Weihong Xiao, Esther Kim, Bo Jiang, Marc T. Goodman, Maria Sibug-Saber, Wendy Cozen, Lihua Liu, Charles F. Lynch, Nicolas Wentzensen, Richard C. Jordan, Sean F. Altekruse, William F. Anderson, Philip S. Rosenberg, Maura L. Gillison - Journal of Clinical Oncology 2011 cited by 3,606

  6. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

    Authors: Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Richard C. Jordan, Weiqiang Zhao, Erich M. Sturgis, Barbara Burtness, John A. Ridge, Jolie Ringash, James M. Galvin, Min Yao, Shlomo A. Koyfman, Dukagjin Blakaj, Mohammed A. Razaq, A. Dimitrios Colevas, Jonathan J. Beitler, Christopher U. Jones, Neal Dunlap, Samantha A. Seaward, Sharon A. Spencer, Thomas J. Galloway, Jack Phan, James J. Dignam, Quynh‐Thu Le - The Lancet 2018 cited by 1,295

  7. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Authors: Ezra E.W. Cohen, R. Bryan Bell, Carlo Bifulco, Barbara Burtness, Maura L. Gillison, Kevin J. Harrington, Quynh‐Thu Le, Nancy Y. Lee, Rom S. Leidner, Rebecca Lewis, Lisa Licitra, Hisham Mehanna, Loren K. Mell, Adam Raben, Andrew G. Sikora, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg, Robert L. Ferris - Journal for ImmunoTherapy of Cancer 2019 cited by 738

  8. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

    Authors: Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas R. Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas J. Galloway, J.L. Geiger, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, P. Savvides, David A. Schwartz, Jatin P. Shah, David J. Sher, Maie A. St. John, Randal S. Weber, Gregory S. Weinstein, Frank Worden, Justine Y. Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2022 cited by 531

  9. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)

    Authors: Robert L. Ferris, Yael Flamand, Gregory S. Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J. Garcia, Christine H. Chung, Maura L. Gillison, Umamaheswar Duvvuri, Bert W. O'Malley, Enver Ozer, Giovana R. Thomas, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Nabil F. Saba, Miriam Lango, Eduardo Méndez, Barbara Burtness - Journal of Clinical Oncology 2021 cited by 441

  10. Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

    Authors: Maura L. Gillison, Anil K. Chaturvedi, William F. Anderson, Carole Fakhry - Journal of Clinical Oncology 2015 cited by 1,230

  11. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

    Authors: Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, J. Guigay, A. Dimitrios Colevas, Lisa Licitra, Kevin J. Harrington, Stefan Kasper, Everett E. Vokes, Caroline Even, Francis P. Worden, Nabil F. Saba, Lara Carmen Iglesias Docampo, Robert I. Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Mark Lynch, Vijayvel Jayaprakash, Li Li, Maura L. Gillison - Oral Oncology 2018 cited by 800

  12. Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

    Authors: Anil K. Chaturvedi, William F. Anderson, Joannie Lortet‐Tieulent, María Paula Curado, Jacques Ferlay, Silvia Franceschi, Philip S. Rosenberg, Freddie Bray, Maura L. Gillison - Journal of Clinical Oncology 2013 cited by 1,290

  13. Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651

    Authors: Robert I. Haddad, Kevin J. Harrington, Makoto Tahara, Robert L. Ferris, Maura L. Gillison, Jérôme Fayette, Amaury Daste, P. Koralewski, Bogdan Żurawski, Miren Taberna, Nabil F. Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo Girotto, Miguel Ángel Álvarez-Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander Guminski, Urs Müller‐Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Wei Li, Athanassios Argiris - Journal of Clinical Oncology 2022 cited by 158

  14. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

    Authors: Maura L. Gillison - JNCI Journal of the National Cancer Institute 2000 cited by 3,105

  15. Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study

    Authors: Amanda Psyrri, Jérôme Fayette, Kevin J. Harrington, Maura L. Gillison, M-J. Ahn, Shunji Takahashi, Jared Weiss, J-P. Machiels, Shrujal S. Baxi, Alexander Vasilyev, А. А. Карпенко, Mikhail Dvorkin, Ching-Yun Hsieh, S.C. Thungappa, Pedro Pérez Segura, Ihor Vynnychenko, Robert I. Haddad, Stefan Kasper, P. S. Mauz, V. Baker, Philip He, Brent Evans, Sophie Wildsmith, Richard F. Olsson, Alejandro Yovine, John F. Kurland, Nassim Morsli, Tanguy Y. Seiwert - Annals of Oncology 2022 cited by 144

  16. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

    Authors: Sue S. Yom, Pedro A. Torres‐Saavedra, Jimmy J. Caudell, John Waldron, Maura L. Gillison, Ping Xia, Minh Tam Truong, Christina S. Kong, Richard C. Jordan, Rathan M. Subramaniam, Min Yao, Christine H. Chung, J.L. Geiger, Jason W. Chan, Brian O’Sullivan, Dukagjin Blakaj, Loren K. Mell, Wade L. Thorstad, Christopher U. Jones, Robyn Banerjee, C.E. Lominska, Quynh‐Thu Le - Journal of Clinical Oncology 2021 cited by 374

  17. Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    Authors: K. Kian Ang, Qiang Zhang, David I. Rosenthal, Phuc Félix Nguyen‐Tan, Eric J. Sherman, Randal S. Weber, James M. Galvin, James A. Bonner, Jonathan Harris, Adel K. El‐Naggar, Maura L. Gillison, Richard C. Jordan, André Konski, Wade L. Thorstad, Andy Trotti, Jonathan J. Beitler, Adam S. Garden, William J. Spanos, Sue S. Yom, Rita Axelrod - Journal of Clinical Oncology 2014 cited by 832

  18. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability

    Authors: Keiko Akagi, Jingfeng Li, Tatevik Broutian, Hesed Padilla‐Nash, Weihong Xiao, Bo Jiang, James W. Rocco, Theodoros N. Teknos, Bhavna Kumar, Danny Wangsa, Dandan He, Thomas Ried, David E. Symer, Maura L. Gillison - Genome Research 2013 cited by 480

  19. Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration

    Authors: Keiko Akagi, David E. Symer, Medhat Mahmoud, Bo Jiang, Sara Goodwin, Darawalee Wangsa, Zhengke Li, Weihong Xiao, Joe Dan Dunn, Thomas Ried, Kevin R. Coombes, Fritz J. Sedlazeck, Maura L. Gillison - Cancer Discovery 2023 cited by 77

  20. Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

    Authors: Gypsyamber DʼSouza, Aimée R. Kreimer, Raphael P. Viscidi, Michael Pawlita, Carole Fakhry, Wayne M. Koch, William H. Westra, Maura L. Gillison - New England Journal of Medicine 2007 cited by 2,691

  21. Prevalence of Oral HPV Infection in the United States, 2009-2010

    Authors: Maura L. Gillison, Tatevik Broutian, Robert K. L. Pickard, Zhen-yue Tong, Weihong Xiao, Lisa Kahle, Barry I. Graubard, Anil K. Chaturvedi - JAMA 2012 cited by 1,060

  22. Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

    Authors: Renata Ferrarotto, Diana Bell, Maria Laura Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, Danice Torman, Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson, Neil D. Gross - Clinical Cancer Research 2020 cited by 127

  23. Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Authors: Kevin J. Harrington, Robert L. Ferris, Maura L. Gillison, Makoto Tahara, A. Argiris, Jérôme Fayette, Michael Schenker, Åse Bratland, John Walker, Peter Grell, Caroline Even, Christine H. Chung, Rebecca Redman, Alexandre Coutté, Sébastien Salas, Clíona Grant, Sérgio de Azevedo, Denis Soulières, Aaron R. Hansen, Wei Li, Tariq Aziz Khan, Karen Miller-Moslin, Mustimbo Roberts, Robert I. Haddad - JAMA Oncology 2023 cited by 72

  24. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    Authors: Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, A. Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E. Vokes, Francis P. Worden, Nabil F. Saba, Naomi Kiyota, Robert I. Haddad, Makoto Tahara, Viktor Grünwald, James W. Shaw, Manish Monga, Mark Lynch, Fiona Taylor, Michael DeRosa, L Morrissey, Kim Cocks, Maura L. Gillison, J. Guigay - The Lancet Oncology 2017 cited by 430